ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer.

Tamara Muliaditan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.